InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Crandell Keith, Director. Officer active across 6 companies, notably Quanterix Corp. Aggregated, 26 disclosures have been recorded. Breakdown: 2 buys · 2 sells. Total volume traded: €15.5m. History available since 9 March 2021. The latest transaction was disclosed on 1 July 2026 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Crandell Keith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations26 total
16,000 shares@ US$1.030.030% mcap29.3% of flowCommon StockSEC:0001012975-26-000622:0
16,000 shares@ US$2.490.071% mcap70.7% of flowCommon StockSEC:0001012975-26-000622:1
14,083 sharesCommon StockSEC:0001219039-26-000002:0
5,095 shares0Common StockSEC:0001214659-26-001352:0
11,364 sharesCommon StockSEC:0001562180-25-004804:0
4,472 shares0Common StockSEC:0001214659-25-002256:0
7,777 sharesCommon StockSEC:0001562180-24-005066:0
589,743 sharesCommon StockSEC:0000950170-24-041842:0
363,637 shares@ US$5.50100.0% of flowCommon StockSEC:0001062993-24-002841:0
Canonical exit: 8 May 2024 (T+90)
5,815 shares0Common StockSEC:0001214659-24-002246:0
1,600,000 sharesClass A Common StockSEC:0001062993-23-016234:0
4,771 sharesCommon StockSEC:0001562180-23-005309:0
1,170 shares@ US$11.1622.2% of flowCommon StockSEC:0001562180-23-003402:0
8,212 shares0Common StockSEC:0001214659-23-001899:0
8,083 shares0Common StockSEC:0001562180-23-000101:0
1,326 shares@ US$10.4826.2% of flowCommon StockSEC:0001562180-22-007043:0
893 shares@ US$16.7926.5% of flowCommon StockSEC:0001562180-22-005559:0
1,379 sharesCommon Stock, par value $0.001SEC:0001562180-22-005192:0
492 shares@ US$30.4725.1% of flowCommon StockSEC:0001562180-22-003261:0
3,491 shares0Common StockSEC:0001209191-22-008625:0
189,311 shares0Common StockSEC:0001562180-22-000232:0
189,311 shares0Common StockSEC:0001562180-21-006302:0
1,412 shares@ US$106.93100.0% of flowCommon StockSEC:0001062993-21-007502:0
1,600,000 shares@ US$10.00100.0% of flowClass A Common StockSEC:0000899243-21-031427:0
Canonical exit: 28 Oct 2021 (T+90)
213,740 shares0Common StockSEC:0001104659-21-089485:0
25 of 26 declarations
About Crandell Keith
CRANDELL KEITH is a Director and has 26 filings in total. Across the 26 sampled recent filings, the period runs from 2021-07-06 to 2026-07-06, with EUR 15309318 of buys and EUR 163663 of sells, and the stated transaction nature is Attribution. The recent filings concern DA32 Life Science Tech Acquisition Corp., Sana Biotechnology, Inc., Twist Bioscience Corp, Boundless Bio, Inc., and Quanterix Corp.
